Aseptic Technologies

Aseptic Technologies’ core expertise is de-risking aseptic fill&finish operations.

The AT-Closed Vial® Technology, the only trustworthy solution for deep cold storage, is widely used for Cell and Gene Therapy since 2009, making Aseptic Technologies the industry leader for this application.

Visit us during Interphex on booth 3140 (SKAN US Inc.)

scroll down

Crystal® L1 Robot Line

Easy to deploy fill&finish solution


Installed and qualified in 1 week

High flexibility


Switch from batch to batch, product to product with minimal change over time

Crystal® L1 Robot Line

Minimum ressource with maximal outcome


Less validation work

Electricity only for operation

Small footprint

Low COG

video 

Crystal® L1 Robot Line is a flexible platform accomodating your project’s needs

Ready for integration

In RABS

Integrated with SKAN isolator

Contact Aseptic Technologies

HEADQUARTER
Rue Camille Hubert, 7-9
5032 Gembloux / Les Isnes
BELGIUM

Tel. : +32 81 409 410

US CONTACT
SKAN US, Inc.
7409 ACC Boulevard, S. 200
Raleigh, NC - USA

Tel. : +1 919 354 6341

Go to article: Home | The absence of antivenomGo to article: In this issueGo to article: Daiichi JitsugyoGo to article: ContentsGo to article: Capsugel Company InsightGo to article: CapsugelGo to article: NewsGo to article: Scandinavian Health Ltd.Go to article: International Cannabis and Cannabinoid Institute (ICCI) Company InsightGo to article: International Cannabis and Cannabinoid Institute (ICCI)Go to article: The pharma industry briefingGo to article: TSS Company InsightGo to article: TSS ABGo to article: Action Medical Research: celebrating decades of discovery Go to article: Swiss WorldCargoGo to article: Gerteis Company InsightGo to article: GerteisGo to article: Moehs Iberica SLGo to article: Owen MumfordGo to article: How government policy has shaped China’s pharma phenomenonGo to article: HOF Sonderanlagenbau Company InsightGo to article: HOF SonderanlagenbauGo to article: Novo NordiskGo to article: Snake venom in pharma; access to antivenom is a topic that needs attentionGo to article: Phoenix Group Company InsightGo to article: Phoenix Group Go to article: ME Logistic ServicesGo to article: Discussing drug policy reform with psychedelics campaigner Amanda FeildingGo to article: Finnair Cargo | Company InsightGo to article: Finnair CargoGo to article: Aseptic TechnologiesGo to article: False flags: are search engines benefiting rogue online pharmacies?Go to article: CBDepot Company InsightGo to article: CBDepotGo to article: Wilco Company Insight Go to article: WilcoGo to article: The Mighty: how patients and pharma align in the age of social media Go to article: Pharma Support Services Company InsightGo to article: Pharma Support ServicesGo to article: MicronovaGo to article: Inside Italy’s pharmaceutical industry Go to article: KlingeGo to article: BEAGo to article: Erdmann Design SwitzerlandGo to article: Inside the UK’s first vaccines innovation centreGo to article: AralabGo to article: Applikon BiotechnologyGo to article: BaxterGo to article: NymiGo to article: Fostering closer collaboration between manufacturing & regulatory functionsGo to article: EmisphereGo to article: SephaGo to article: Contract Pharmaceuticals Limited CanadaGo to article: EventsGo to article: Pfanstiehl Company InsightGo to article: PfanstiehlGo to article: Next issueGo to article: PolpharmaGo to article: BioAdvice